Blog

Even with multiple COVID-19 vaccines in the equation, thousands of people in critical conditions require effective treatment. Could stem cell therapy be the answer? 

Every cloud has a silver lining. COVID-19 pandemic has brought a lot of pain and suffering, but it also helped to speed medical innovations that are going to stay with us.

Recently, a new COVID-19 vaccine produced by Johnson & Johnson has entered the market. What do we know about it, and how does it impact the vaccination plan? 

The euphoria from the beginning of vaccination against COVID-19 is disturbed by discovering several distinct virus variants that could escape the protection of the current vaccines. Here we discuss perhaps the most worrying variant of the time, first identified in South Africa. 

Compared with the usual vaccine development process, we have witnessed an unprecedented effort resulting in multiple COVID-19 vaccines developed in under a year. It is only natural that people have many questions, but the sheer amount of information might be overwhelming. Here we answer some of the frequently asked questions on COVID-19 vaccines. 

Vaccination is among the biggest achievements of medicine. But even though vaccines have saved millions of lives, people are still suspicious of them. Let’s look at the reasons why some people are opposed to vaccines.

At the beginning of 2021, many countries have approved more than one COVID-19 vaccine. What are the differences between the available options? Here we compare the three most-discussed COVID-19 vaccines. 

Approval of several vaccines against COVID-19 developed in under a year elicits both caution and optimism. Do they work, and more importantly - are they safe? Let us look at the first vaccine approved in western countries - BNT162b2 developed by Pfizer/BioNTech.

The mass culling of farmed minks due to the spread of the novel coronavirus came as a shock to most. Was it a necessary measure or a better-safe-than-sorry precaution? Should we be wary of not only other people but animals as well?